Location: Home
  • search
  • go
  • Relate News
  • 2/9/2022GSK Reports Q4 and FY2021 Performance with China Related Mentions
  • 2/8/2022Sanofi Reports Slowing Chinese Growth in Q4/2021
  • 2/8/2022MSD's China Sales Skyrocketed Driven by Strong HPV Vaccine Growth
  • 2/8/2022Novartis China Witness 10% Innovative Medicine Sales Growth in 2021 De...
  • 2/8/2022FDA Changes Tune On China-Developed Drugs as Lilly and Innovent Draws ...
  • 2/7/2022Mybio Publishes the 2021 China Pharma BD Transactions Report
  • 2/7/2022Aurealis and Xbiome Entered a License Deal for AUP-16 Cell/Gene The...
  • 2/7/2022U.S. Adds Wuxi Biologics to 'Unverified List'
  • 2/7/2022MIIT: China to Beef Up Anti-monopoly Efforts in Pharma Industry
  • 2/7/2022Why Chinese Drugmakers Fail to Reach for the STAR (PharmaDJ)
  • 1/30/2022China Issues the 14th Five Year Plan for Pharmaceutical Industry Devel...
  • 1/30/2022NHSA Issues the Interim Measures for Handling Tips Related to Supervis...
  • 1/30/2022Recent Executive Moves
  • 1/30/2022Financial-related Company News Digest
  • 1/29/2022NHSA Publicizes Scandal of Basic Medical Insurance Frauds Involving As...
  • 1/28/2022NHC Holds the 2022 National Health Working Conference
  • 1/28/2022NMPA Suspends Import, Sales and Use of JWLS's Fat Emulsion Product in ...
  • 1/27/2022CDE Issues the Guidelines for Clinical Trial Protocol Design for Once ...
  • 1/26/2022NMPA Announces Package Insert Revision of Numerous Drug Products
  • 1/26/202293 Listed MedPharm Cos Release 2021 Performance Guidance amid Weakness
  • 1/26/2022China Designates Shenzhen as Pilot Zone for Improved Market Access wit...
  • 1/26/2022Information Collection on the 7th VBP Initiated at Numerous Provinces
  • 1/25/2022Five Chinese Drug Companies to Make Merck's Covid-19 Pills for Poor Co...
  • 1/25/2022BPL Wins Chinese Approval to Market ALBUMINEX 25% in China
  • 1/25/2022CDE Issues the Technical Guidance on Clinical Protocol for Teriparatid...
  • 1/25/2022Protecting Pharmaceutical Trademarks in China and Taiwan
  • 1/24/2022Eluminex Biosciences Acquires Zuretinol Acetate from Retinagenix Holdi...
  • 1/24/2022Amagma Therapeutics Announces Strategic Partnership with Innovent Biol...
  • 1/23/2022WuXi STA Opens Its First Parental Formulation Manufacturing Line
  • 1/21/2022Recent Executive Moves
  • Page:49/333 Total number of articles:9989: [First][<<] [47] [48] [49] [50] [51] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group